Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis

Overview of attention for article published in Psychopharmacology, October 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 10,077 followers.

Sure wish there was some explanation for why schizophrenia is a risk factor for diabetes. https://t.co/y5TlD7j7zs https://t.co/AugF5tSmkY

RT @Scottbteasdale: 1yr metabolic effects of 3 antipsychotics in drug-naive FEP = sig increments in BMI, Tot Chol, LDL, TGs & TG/HDL https:…

RT @Scottbteasdale: 1yr metabolic effects of 3 antipsychotics in drug-naive FEP = sig increments in BMI, Tot Chol, LDL, TGs & TG/HDL https:…

RT @Scottbteasdale: 1yr metabolic effects of 3 antipsychotics in drug-naive FEP = sig increments in BMI, Tot Chol, LDL, TGs & TG/HDL https:…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.